Lilly pours another $10M into public-private Indiana research institute

Eli Lilly ($LLY) is pitching in $10 million to fund the Indiana Biosciences Research Institute, a public-private life sciences organization launched by local luminaries including Cook Medical, Biomet and Roche Diagnostics ($RHHBY). Lilly already contributed to the organization's $50 million startup funding, and the company's latest grant is designed to encourage collaboration between government, academia and industry on new drugs, devices and diagnostics. More

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.